Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6490
    +0.0001 (+0.02%)
     

  • OIL

    82.96
    -0.40 (-0.48%)
     

  • GOLD

    2,345.30
    +3.20 (+0.14%)
     

  • Bitcoin AUD

    99,831.62
    -3,070.87 (-2.98%)
     

  • CMC Crypto 200

    1,406.35
    -17.75 (-1.25%)
     

  • AUD/EUR

    0.6070
    +0.0014 (+0.23%)
     

  • AUD/NZD

    1.0951
    +0.0021 (+0.19%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,531.47
    +60.00 (+0.34%)
     

  • FTSE

    8,039.09
    -5.72 (-0.07%)
     

  • Dow Jones

    38,368.97
    -134.72 (-0.35%)
     

  • DAX

    18,062.53
    -75.12 (-0.41%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

Chimerix (CMRX) Q2 2022 Earnings Call Transcript

Motley Fool Transcribing, The Motley Fool
·29-min read
Chimerix (CMRX) Q2 2022 Earnings Call Transcript

With me on today's call are president and chief executive officer, Mike Sherman; chief medical officer, Allen Melemed; chief financial and business officer, Mike Andriole; chief science officer, Randall Lanier; and our chief technology officer of Imipridones, Josh Allen. Before we begin, I'd like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties and other factors.

Continue reading